| Name | Trace Amine-Associated Receptor (TAAR) Modulator Therapy for Neurodegeneration |
| Summary | Therapeutic modulation of TAAR receptors (TAAR1, TAAR5, TAAR6, TAAR8, TAAR9) for Alzheimer's, Parkinson's, ALS, and Huntington's disease. Trace amine dysregulation contributes to neurodegeneration through dopaminergic, serotonergic, and noradrenergic signaling pathways. |